JSE LIMITED - Dealings in securities by directors and prescribed officers

Dealings in securities by directors and prescribed officers

JSE LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
Share Code: JSE
ISIN Code: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")

DEALINGS IN SECURITIES BY DIRECTORS AND PRESCRIBED OFFICERS

In accordance with the terms of the JSE's long-term incentive scheme ("LTIS
2018"), share awards granted in 2021 and 2022 have vested in the hands of
executive committee members (executive directors and prescribed officers)
of the JSE (the "Participants"). Share awards are subject to corporate
performance conditions and, where the performance conditions are not
achieved, the relevant portion of the share award is forfeited.

On instruction of the named Participants below, the JSE LTIS 2018 Trust
sold 91 682 vested ordinary shares ("LTIS 2018 shares") to settle the
income tax due on vesting. These LTIS 2018 shares were sold on-market and
at a volume-weighted average price ("VWAP") of R119.6087 per ordinary
share. The total transaction value amounted to R10 965 965.

The daily high, low and VWAP for the various transactions effected by the
JSE LTIS 2018 Trust were:

Dates in 2025     Number of JSE   Daily VWAP of     Daily highest     Daily lowest
that JSE               ordinary      JSE shares    price received   price received
ordinary            shares sold            sold        (cents per       (cents per
shares were                          (cents per            share)           share)
sold                                     share)

9 April                  11 072       12122.94              12222           12100

10 April                 57 990       11956.62              12363           11900

11 April                 22 620       11892.44              12000           11821


The transactions per Participant in LTIS 2018 Allocation 4_2 (2021) were:

Name            Role          Number of    Number of      Number of      Value of
                              LTIS 2018    LTIS 2018      LTIS 2018   Transaction
                                 shares       shares         shares
                                awarded       vested           sold
L Fourie        Executive        41 490       27 715         13 042    R1 559 937
                director
A Greenwood     Prescribed        13 004       8 687          4 087      R488 841
                Officer
V Lee           Prescribed        9 994        6 676          3 141      R375 691
                Officer
I Monale        Prescribed        11 606       7 753          3 648      R436 333
                Officer
M Randall       Prescribed        10 769       7 194          3 385      R404 875
                Officer
V Reddy         Prescribed        12 412       8 291          3 901      R466 593
                Officer

The transactions per Participant in LTIS 2018 Allocation 5_1 (2022) were:

Name            Role         Number of   Number of   Number of      Value of
                             LTIS 2018   LTIS 2018   LTIS 2018   Transaction
                                shares      shares      shares
                               awarded      vested        sold
L Fourie        Executive       57 295      49 159      23 133    R2 766 909
                director
A Greenwood     Prescribed      27 360      23 474      11 052    R1 321 915
                Officer
V Lee           Prescribed      11 250       9 652       4 542      R543 262
                Officer
I Monale        Prescribed      13 065      11 210       5 275      R630 936
                Officer
M Randall       Prescribed      12 710      10 905       5 131      R613 712
                Officer
V Reddy         Prescribed      28 100      24 110      11 345    R1 356 961
                Officer

All interests are direct, beneficial and clearance to deal was granted by
the Chairman of the Board.

Sandton
14 April 2025

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 14-04-2025 05:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.